Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Single Center Trial Evaluating the Efficacy and Safety of Diazepam in GAD65 Associated Epilepsy

NCT05361447 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05361447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05361447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Single Center Trial Evaluating the Efficacy and Safety of Diazepam in GAD65 Associated Epilepsy
Lead sponsor
Mayo Clinic
Phase
Phase 1/2
Overall status
Withdrawn
Start date
January 11, 2023
Completion date
December 13, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gad 65 antibody-associated epilepsy